Australia's Zelira Therapeutics surges on $33 million funding for drug trial

Zelira Therapeutics

15/01/2026 23:44

** Shares of Zelira Therapeutics ZLD.AX rise as much as 151.4% to A$0.905, hitting their highest level since Nov. 15, 2024

** Stock marks its biggest intraday pct gain since May 31, 2023

** Biopharma co inks deal with TGC Biotechnology fund to raise $33 million

** Says funding for its HOPE1 SPV, financial structure created by co to fund development & clinical trials for its cannabinoid drug HOPE® 1

** Stock has gained 125% so far this week, up nearly 100% YTD

 (Reporting by Rajasik Mukherjee in Bengaluru)

 ((Rajasik.Mukherjee@thomsonreuters.com))